RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin‐resistant ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin‐resistant ovarian cancer

Published:2019-02-15 Issue:4 Volume:33 Page:5350-5365
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Gong Shipeng¹,Chen Yongning¹,Meng Fanliang¹,Zhang Yadi¹,Wu Huan²,Li Chanyuan¹,Zhang Guangping³

Affiliation:

1. Department of Obstetrics and GynecologyNanfang HospitalSouthern Medical University Guangzhou China

2. Department of Obstetrics and GynecologyThe Second Affiliated HospitalChongqing Medical University Chongqing China

3. Department of GynecologyPeople's Hospital of Huadu District Guangzhou China

Funder

Guangdong Science and Technology Department

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201801529RR

Reference45 articles.

1. miR‐199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α;Feng X.;OncoTargets Ther.,2017

2. A review of the current evidence for maintenance therapy in ovarian cancer

3. Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells

4. Glutathione-s-transferase modified electrodes for detecting anticancer drugs

5. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer;International Journal of Biological Sciences;2024

2. Comprehensive analysis of prognostic value and immune infiltration of Regulator of Chromosome Condensation 2 in lung adenocarcinoma;Journal of Cancer;2024

3. Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancers;Aging;2022-11-27

4. Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker;Frontiers in Immunology;2022-11-17

5. The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma;Cancer Letters;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3